Anupam Rasayan India Ltd (ANURAS) — Corporate Action | 28 September 2026

28 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Anupam Rasayan completes 2.12% acquisition of Bliss GVS Pharma, achieving 47.95% total stake and promoter status.

💡 Investor Takeaway

The company now controls Bliss GVS Pharma with a majority promoter stake, enabling strategic integration in the pharmaceutical value chain.

Anupam Rasayan India announced it acquired an additional 2.12% stake in Bliss GVS Pharma through a 22.5 lakh share purchase on 28 September 2026, completing its 47.95% total holding and achieving promoter status alongside the PAC, which together now own 50.07% of Bliss. The acquisition was executed via cash consideration of [amount not verified] at [amount not verified]per share, with the target's FY2025-26 turnover at [amount not verified].

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This

About Anupam Rasayan India Ltd (ANURAS)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹13,509.81 CrP/E: 60.0ROE: 5.3%ROCE: 8.3%Div Yield: 0.13%

View full ANURAS stock details →

📡 Get AI alerts when ANURAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANURAS — Free

💡 Ask AI about this filing

"What is the valuation multiple relative to Bliss's FY25 revenue?""How will the acquisition impact Anupam's EPS and margins?""What are the specific cost synergy targets for the combined entity?"

Ask AI Free →

📊 More ANURAS filings

🟡 Board Meeting — 23 September 2026Anupam Rasayan India announced execution of key security documents related to a proposed INR 300 cro...
🔴 Corporate Action — 21 September 2026Anupam Rasayan India announced the allotment of 14,500 senior secured rated unlisted redeemable non-...
🟡 Board Meeting — 19 September 2026Anupam Rasayan approved issuing up to 16,000 secured NCDs worth **₹160 crores** on September 19, 202...
🟡 Board Meeting — 19 September 2026Anupam Rasayan India approved up to 16,000 secured NCDs worth **₹160 crores** at 10.25% coupon via p...
🟡 Board Meeting — 17 September 2026Anupam Rasayan India approved execution of security documents for Mates Visa Consultancy's up to INR...

See all ANURAS filings →

🔥 Also filed on 28 September 2026

JSLJindal Stainless LtdCorporate Action GODREJPROPGodrej Properties LtdAnnouncement MANINFRAMan Infraconstruction LtdAnnouncement KPILKalpataru Projects International LtdAnnouncement SUNPHARMASun Pharmaceutical Industries LtdAnnouncement JUBLPHARMAJubilant Pharmova LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANURAS files new disclosures

Track ANURAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.